Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...

Union Budget boosts research and innovation with significant funding for science, technology, and biotechnology sectors.

The next phase of Kilroy's big Oyster Point project is seeing interest from tech and financial services as well as biotech, ...

The grants have been the source of new treatments for cancer, heart disease, diabetes, strokes and H.I.V.; wonder drugs like ...

The settlement in U.S. v. Gilead could disturb the model of public-private partnership that sustains many of the United ...

Leading American genomic sequencing firm Illumina says it is evaluating Beijing’s announcement with hope of ‘positive ...

A joint report by the Institute for Deep Tech Innovation (DEEP) at ESMT Berlin and the Bertelsmann Stiftung highlights Germany’s immense innovation potential in the biotech sector. However, this ...

Variant Bio recently announced a multimillion-dollar deal with a pharmaceutical company, and some of that money will go to ...

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for drug discovery and development ...

The fundraising was co-led by Radical Ventures, which specialises in AI software companies, and European healthcare venture firm Sofinnova Partners. Other investors include Jeff Dean, Google’s chief ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...